Particularly, the NF-κB mediated signaling, a well-established dominant transduction pathway for the development and progression of a variety of tumors, was involved in CXCR2-driven ovarian cancer progression (Fig 2). This evidence concerns the gene CXCR2 and ovarian cancer.